Cargando…
Neuro-ophthalmic manifestations of mitochondrial disorders and their management
The visual system has high metabolic requirements and is therefore particularly vulnerable to mitochondrial dysfunction. The most commonly affected tissues include the extraocular muscles, photoreceptors, retinal pigment epithelium, optic nerve and visual cortex. Hence, the most common manifestation...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7971441/ https://www.ncbi.nlm.nih.gov/pubmed/33767954 http://dx.doi.org/10.4103/tjo.tjo_68_20 |
_version_ | 1783666613223948288 |
---|---|
author | Lock, Jane H. Irani, Neha K. Newman, Nancy J. |
author_facet | Lock, Jane H. Irani, Neha K. Newman, Nancy J. |
author_sort | Lock, Jane H. |
collection | PubMed |
description | The visual system has high metabolic requirements and is therefore particularly vulnerable to mitochondrial dysfunction. The most commonly affected tissues include the extraocular muscles, photoreceptors, retinal pigment epithelium, optic nerve and visual cortex. Hence, the most common manifestations of mitochondrial disorders are progressive external ophthalmoplegia, macular pattern dystrophy, pigmentary retinopathy, optic neuropathy and retrochiasmal visual field loss. With the exception of Leber hereditary optic neuropathy and stroke-like episodes seen in mitochondrial encephalopathy, lactic acidosis and stroke-like episodes, the majority of neuro-ophthalmic manifestations have an insidious onset. As such, some patients may not recognize subtle progressive visual symptoms. When mitochondrial disorders are highly suspected, meticulous examination performed by an ophthalmologist with targeted ancillary testing can help confirm the diagnosis. Similarly, neuro-ophthalmic symptoms and signs may be the first indication of mitochondrial disease and should prompt systemic investigations for potentially life-threatening associations, such as cardiac conduction defects. Finally, the ophthalmologist can offer symptomatic treatments for some of the most disabling manifestations of these disorders. |
format | Online Article Text |
id | pubmed-7971441 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-79714412021-03-24 Neuro-ophthalmic manifestations of mitochondrial disorders and their management Lock, Jane H. Irani, Neha K. Newman, Nancy J. Taiwan J Ophthalmol Review Article The visual system has high metabolic requirements and is therefore particularly vulnerable to mitochondrial dysfunction. The most commonly affected tissues include the extraocular muscles, photoreceptors, retinal pigment epithelium, optic nerve and visual cortex. Hence, the most common manifestations of mitochondrial disorders are progressive external ophthalmoplegia, macular pattern dystrophy, pigmentary retinopathy, optic neuropathy and retrochiasmal visual field loss. With the exception of Leber hereditary optic neuropathy and stroke-like episodes seen in mitochondrial encephalopathy, lactic acidosis and stroke-like episodes, the majority of neuro-ophthalmic manifestations have an insidious onset. As such, some patients may not recognize subtle progressive visual symptoms. When mitochondrial disorders are highly suspected, meticulous examination performed by an ophthalmologist with targeted ancillary testing can help confirm the diagnosis. Similarly, neuro-ophthalmic symptoms and signs may be the first indication of mitochondrial disease and should prompt systemic investigations for potentially life-threatening associations, such as cardiac conduction defects. Finally, the ophthalmologist can offer symptomatic treatments for some of the most disabling manifestations of these disorders. Wolters Kluwer - Medknow 2020-12-04 /pmc/articles/PMC7971441/ /pubmed/33767954 http://dx.doi.org/10.4103/tjo.tjo_68_20 Text en Copyright: © 2020 Taiwan J Ophthalmol http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Review Article Lock, Jane H. Irani, Neha K. Newman, Nancy J. Neuro-ophthalmic manifestations of mitochondrial disorders and their management |
title | Neuro-ophthalmic manifestations of mitochondrial disorders and their management |
title_full | Neuro-ophthalmic manifestations of mitochondrial disorders and their management |
title_fullStr | Neuro-ophthalmic manifestations of mitochondrial disorders and their management |
title_full_unstemmed | Neuro-ophthalmic manifestations of mitochondrial disorders and their management |
title_short | Neuro-ophthalmic manifestations of mitochondrial disorders and their management |
title_sort | neuro-ophthalmic manifestations of mitochondrial disorders and their management |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7971441/ https://www.ncbi.nlm.nih.gov/pubmed/33767954 http://dx.doi.org/10.4103/tjo.tjo_68_20 |
work_keys_str_mv | AT lockjaneh neuroophthalmicmanifestationsofmitochondrialdisordersandtheirmanagement AT iraninehak neuroophthalmicmanifestationsofmitochondrialdisordersandtheirmanagement AT newmannancyj neuroophthalmicmanifestationsofmitochondrialdisordersandtheirmanagement |